Christopher Roger King MD, PhD

Dr. King is Associate Professor of Radiation Oncology and Urology at UCLA. He received his MD from Boston University, and completed his residency training in Radiation Oncology at Yale. Before joining UCLA he was Associate Professor at Stanford. Dr. King also holds a Ph.D. in Astrophysics from Yale University.
Dr. King specializes in the treatment of genitourinary cancers and has pioneered the use of stereotactic body radiation therapy for the treatment of prostate cancer. His research explores novel treatment techniques for prostate, kidney, and bladder cancer.